Mirabegron 68180-0151
Product NDC
68180-0151- Manufacturer
- Lupin Pharmaceuticals, Inc.
- Dosage Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 19, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA209485
Need to source Mirabegron? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Mirabegron | 25 mg/1 |
Drug Class
beta3-Adrenergic Agonist [EPC]Adrenergic beta3-Agonists [MoA]Cytochrome P450 2D6 Inhibitors [MoA]
Packaging Options(2)
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68180-151-06)
90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68180-151-09)